Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
March 11, 2020
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins
Hanna Ruhanen, P A Nidhina Haridas, Ilenia Minicocci, et al.
Journal of Clinical Lipidology
|
May 12, 2018
Clinical and biochemical features of different molecular etiologies of familial chylomicronemia
Robert A Hegele, Amanda J Berberich, Matthew R Ban, et al.
Scientific Reports
|
March 1, 2018
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
Alessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, et al.
Journal of Clinical Lipidology
|
December 2, 2025
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access program
Antonina Giammanco, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Journal of Internal Medicine
|
June 11, 2026
Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humans
Marcello Arca, Elias Björnson, Laura D'Erasmo, et al.
Atherosclerosis
|
September 24, 2022
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome
Angelo B Cefalù, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Atherosclerosis
|
July 1, 2026
Optimized flow cytometry assay for functional characterization of variants of uncertain significance in familial hypercholesterolemia
Stella Covino, Alessia Di Costanzo, Alessandra Rossi, et al.
International Journal of Molecular Sciences
|
July 20, 2021
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways
Vittoria Cammisotto, Francesco Baratta, Valentina Castellani, et al.
Atherosclerosis
|
December 29, 2016
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage
Alessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, et al.
Atherosclerosis
|
March 28, 2026
Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry
Willemijn Am Schonck, G Kees Hovingh, Dirk J Blom, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
March 11, 2020
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins
Hanna Ruhanen, P A Nidhina Haridas, Ilenia Minicocci, et al.
Journal of Clinical Lipidology
|
May 12, 2018
Clinical and biochemical features of different molecular etiologies of familial chylomicronemia
Robert A Hegele, Amanda J Berberich, Matthew R Ban, et al.
Scientific Reports
|
March 1, 2018
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
Alessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, et al.
Journal of Clinical Lipidology
|
December 2, 2025
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access program
Antonina Giammanco, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Journal of Internal Medicine
|
June 11, 2026
Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humans
Marcello Arca, Elias Björnson, Laura D'Erasmo, et al.
Atherosclerosis
|
September 24, 2022
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome
Angelo B Cefalù, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Atherosclerosis
|
July 1, 2026
Optimized flow cytometry assay for functional characterization of variants of uncertain significance in familial hypercholesterolemia
Stella Covino, Alessia Di Costanzo, Alessandra Rossi, et al.
International Journal of Molecular Sciences
|
July 20, 2021
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways
Vittoria Cammisotto, Francesco Baratta, Valentina Castellani, et al.
Atherosclerosis
|
December 29, 2016
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage
Alessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, et al.
Atherosclerosis
|
March 28, 2026
Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry
Willemijn Am Schonck, G Kees Hovingh, Dirk J Blom, et al.
Page
of 8